PEOPLE - Cohesion Technologies (US) makes appointment:
This article was originally published in Clinica
George Daniloff has been appointed vice-president of R&D at Cohesion Technologies of Palo Alto, California. Dr Daniloff, who has 12 years of start-up and large company experience, was recently chief scientific officer of Sensors for Medicine and Science.
You may also be interested in...
The company is looking at deals in the $2bn to $5bn range, CEO Paul Hudson told investors, but premiums for assets are high and Sanofi is looking at earlier-stage opportunities as a result.
The physician who led the first first-in-human robotic-assisted neurovascular intervention with Corindus’ CorPath GRX system believes the technology could revolutionize neurovascular intervention by allowing a centralized interventional team to remotely treat patients.